Literature DB >> 33642785

Demographic and clinical characteristics of dogs with centroblastic lymphoma.

Katarzyna Kliczkowska-Klarowicz1, Dariusz Jagielski2, Michał Czopowicz3, Rafał A Sapierzyński1.   

Abstract

BACKGROUND AND AIM: Centroblastic lymphoma (CBL) is the most common morphological type of lymphoma found in dogs; it is usually identified through cytology in veterinary clinical practice. This study aimed to identify the demographic and clinical characteristics of dogs with CBL that was diagnosed with cytology and immunocytochemistry.
MATERIALS AND METHODS: Dogs with a suspicion of lymphoma were diagnosed by cytology supported by immunocytochemistry with the use of the updated Kiel classification adapted for dogs. During the analyzed time period, 336 lymphomas were diagnosed in dogs, including 171 cases of CBL. Epidemiological and clinical data from the dogs with CBL were provisionally collected.
RESULTS: The epidemiology analysis revealed an increased risk of CBL in Rottweilers, golden retrievers, and Bernese mountain dogs. At admission, most of the dogs displayed generalized lymphadenopathy with spleen and liver enlargement. The most common hematological abnormality was leukocytosis due to neutrophilia. The most common biochemical abnormality was elevated alanine aminotransferase and alkaline phosphatase activities and selective hypoproteinemia due to hypoalbuminemia.
CONCLUSION: Rottweilers, Bernese mountain dogs, and golden retrievers appear to be overrepresented among dogs with CBL. CBL is usually diagnosed at an advanced clinical stage according to the World Health Organization; however, it is usually accompanied by only minor hematological and biochemical abnormalities. Copyright: © Kliczkowska-Klarowicz, et al.

Entities:  

Keywords:  Bernese mountain dogs; Golden Retrievers; Rottweilers; clinical stage; cytology; epidemiology; fine-needle biopsy; immunophenotype; lymphoma

Year:  2021        PMID: 33642785      PMCID: PMC7896917          DOI: 10.14202/vetworld.2021.49-55

Source DB:  PubMed          Journal:  Vet World        ISSN: 0972-8988


  29 in total

1.  Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.

Authors:  O Davies; B Szladovits; G Polton; O A Garden; C Leo; A Lara-Garcia
Journal:  Vet Comp Oncol       Date:  2017-12-22       Impact factor: 2.613

2.  Peripheral blood abnormalities and bone marrow infiltration in canine large B-cell lymphoma: is there a link?

Authors:  V Martini; E Melzi; S Comazzi; M E Gelain
Journal:  Vet Comp Oncol       Date:  2013-02-18       Impact factor: 2.613

3.  Practical aspects of immunocytochemistry in canine lymphomas.

Authors:  R Sapierzyński
Journal:  Pol J Vet Sci       Date:  2010       Impact factor: 0.821

4.  Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B-cell lymphoma receiving chemoimmunotherapy.

Authors:  Laura Marconato; Valeria Martini; Damiano Stefanello; Pierangelo Moretti; Roberta Ferrari; Stefano Comazzi; Paola Laganga; Fulvio Riondato; Luca Aresu
Journal:  Vet J       Date:  2015-07-14       Impact factor: 2.688

5.  Geographical differences in survival of dogs with non-Hodgkin lymphoma treated with a CHOP based chemotherapy protocol.

Authors:  H Wilson-Robles; C M Budke; T Miller; N Dervisis; A Novosad; Z Wright; D H Thamm; K Vickery; K Burgess; M Childress; J Lori; C Saba; S Rau; M Silver; G Post; K Reeds; S Gillings; S Schleis; T Stein; B Brugmann; C DeRegis; O Smrkovski; J Lawrence; T Laver
Journal:  Vet Comp Oncol       Date:  2017-04-17       Impact factor: 2.613

6.  Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas.

Authors:  C Fournel-Fleury; J P Magnol; P Bricaire; T Marchal; L Chabanne; A Delverdier; P A Bryon; P Felman
Journal:  J Comp Pathol       Date:  1997-07       Impact factor: 1.311

7.  Canine lymphoma: immunocytochemical analysis of fine-needle aspiration biopsy.

Authors:  M Caniatti; P Roccabianca; E Scanziani; S Paltrinieri; P F Moore
Journal:  Vet Pathol       Date:  1996-03       Impact factor: 2.221

8.  Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.

Authors:  V E Valli; P H Kass; M San Myint; F Scott
Journal:  Vet Pathol       Date:  2013-02-26       Impact factor: 2.221

9.  Retrospective analysis of factors affecting clinical outcome following CHOP-based chemotherapy in dogs with primary nodal diffuse large B-cell lymphoma.

Authors:  M O Childress; J A Ramos-Vara; A Ruple
Journal:  Vet Comp Oncol       Date:  2017-11-20       Impact factor: 2.613

10.  Assessment of bone marrow infiltration diagnosed by flow cytometry in canine large B cell lymphoma: prognostic significance and proposal of a cut-off value.

Authors:  Laura Marconato; Valeria Martini; Luca Aresu; Michele Sampaolo; Fabio Valentini; Valentina Rinaldi; Stefano Comazzi
Journal:  Vet J       Date:  2013-06-02       Impact factor: 2.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.